Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 127,562 shares at $445.56 ($57.3M) on 2025-12-03, disclosed to the SEC on 2025-12-05.
Scheduled sale ($57.3M) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $440.40 | 4,469 | $2.0M | 3.4% |
| 2 | $440.40 | 4,469 | $2.0M | 3.4% |
| 3 | $441.26 | 1,320 | $582K | 1.0% |
| 4 | $441.26 | 1,320 | $582K | 1.0% |
| 5 | $443.21 | 2,469 | $1.1M | 1.9% |
| 6 | $443.21 | 2,469 |
| $1.1M |
| 1.9% |
| 7 | $444.36 | 4,352 | $1.9M | 3.4% |
| 8 | $444.36 | 4,352 | $1.9M | 3.4% |
| 9 | $445.56 | 7,899 | $3.5M | 6.1% |
| 10 | $445.56 | 7,899 | $3.5M | 6.1% |
| 11 | $447.05 | 1,152 | $515K | 0.9% |
| 12 | $447.05 | 1,152 | $515K | 0.9% |
| 13 | $448.78 | 2,320 | $1.0M | 1.8% |
| 14 | $448.78 | 2,320 | $1.0M | 1.8% |
| 15 | $449.84 | 5,880 | $2.6M | 4.6% |
| 16 | $449.84 | 5,880 | $2.6M | 4.6% |
| 17 | $451.20 | 5,809 | $2.6M | 4.6% |
| 18 | $451.20 | 5,809 | $2.6M | 4.6% |
| 19 | $452.20 | 15,681 | $7.1M | 12.4% |
| 20 | $452.20 | 15,681 | $7.1M | 12.4% |
| 21 | $453.34 | 10,360 | $4.7M | 8.2% |
| 22 | $453.34 | 10,360 | $4.7M | 8.2% |
| 23 | $455.22 | 2,070 | $942K | 1.6% |
| 24 | $455.22 | 2,070 | $942K | 1.6% |
| Total | $449.20 avg | 127,562 | $57.3M | 100% |
| Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |
| VRTX | SELL | 2024-02-14 | $2.8M | — | Filing → |